[go: up one dir, main page]

UA111785C2 - Композиція для лікування бородавок та спосіб лікування бородавок - Google Patents

Композиція для лікування бородавок та спосіб лікування бородавок

Info

Publication number
UA111785C2
UA111785C2 UAA201412210A UAA201412210A UA111785C2 UA 111785 C2 UA111785 C2 UA 111785C2 UA A201412210 A UAA201412210 A UA A201412210A UA A201412210 A UAA201412210 A UA A201412210A UA 111785 C2 UA111785 C2 UA 111785C2
Authority
UA
Ukraine
Prior art keywords
composition
treatment
warts
way
alkyl ester
Prior art date
Application number
UAA201412210A
Other languages
English (en)
Ukrainian (uk)
Inventor
Флеммінґ Лікт
Original Assignee
А-Б-Б-Е-Кс Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by А-Б-Б-Е-Кс Аб filed Critical А-Б-Б-Е-Кс Аб
Publication of UA111785C2 publication Critical patent/UA111785C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
UAA201412210A 2012-05-28 2012-05-28 Композиція для лікування бородавок та спосіб лікування бородавок UA111785C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE2012/050566 WO2013180606A1 (en) 2012-05-28 2012-05-28 Composition for treatment of warts

Publications (1)

Publication Number Publication Date
UA111785C2 true UA111785C2 (uk) 2016-06-10

Family

ID=49673684

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201412210A UA111785C2 (uk) 2012-05-28 2012-05-28 Композиція для лікування бородавок та спосіб лікування бородавок

Country Status (15)

Country Link
US (1) US10716857B2 (es)
JP (1) JP5934437B2 (es)
KR (1) KR101988693B1 (es)
CN (1) CN104363885A (es)
AU (1) AU2012381141B2 (es)
BR (1) BR112014029590A2 (es)
CA (1) CA2871990C (es)
EA (1) EA026621B1 (es)
HK (1) HK1206633A1 (es)
IL (1) IL235367B (es)
MX (1) MX351512B (es)
SG (1) SG11201407544XA (es)
UA (1) UA111785C2 (es)
WO (1) WO2013180606A1 (es)
ZA (1) ZA201409502B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3018687B1 (fr) * 2014-03-19 2017-04-14 Patrick Lepeytre " composition a base d'acides carboxyliques et son application pour le traitement des hyperkeratoses " -

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN86107485A (zh) * 1986-10-29 1988-05-11 陈黄平 普通白酒勾兑成名酒香型酒技术
US5433950A (en) 1990-05-07 1995-07-18 Schering-Plough Healthcare Products, Inc. Flexible collodion compositions
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
SE513436C2 (sv) 1999-01-21 2000-09-11 Astrid Agholme Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
US7780992B2 (en) 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
KR20060104011A (ko) * 2005-03-29 2006-10-09 바이오이퀄 아게 사마귀 제거, 손발톱 질병의 치료 및 손발톱 관리에적용하기 위한 국소 제형
CN1939539A (zh) 2005-09-29 2007-04-04 瑞士商拜欧伊果公司 疣、指甲疾病、及指甲保养用之局部配方
US8691247B2 (en) * 2006-12-26 2014-04-08 Ad Lunam Labs Inc. Skin rejuvenation cream
CN101686958B (zh) 2007-04-20 2017-02-08 瑞士商拜欧伊果公司 治疗指甲疾病的局部杀真菌药物
JP5248040B2 (ja) 2007-05-25 2013-07-31 リードケミカル株式会社 5−メチル−1−フェニル−2−(1h)−ピリドン含有貼付剤
NL2003419C2 (en) * 2009-09-01 2011-03-02 Shieldmark Zacco Composition for tropical application, uses thereof, applicator device and kit of parts.
ES2658287T3 (es) 2010-12-06 2018-03-09 Abbex Ab Composición para el tratamiento de verrugas

Also Published As

Publication number Publication date
EA026621B1 (ru) 2017-04-28
JP5934437B2 (ja) 2016-06-15
CA2871990A1 (en) 2013-12-05
SG11201407544XA (en) 2014-12-30
IL235367A0 (en) 2014-12-31
JP2015517570A (ja) 2015-06-22
IL235367B (en) 2019-05-30
KR20150035533A (ko) 2015-04-06
CN104363885A (zh) 2015-02-18
HK1206633A1 (en) 2016-01-15
EA201491927A1 (ru) 2015-05-29
KR101988693B1 (ko) 2019-06-12
US10716857B2 (en) 2020-07-21
CA2871990C (en) 2019-07-23
US20150165031A1 (en) 2015-06-18
NZ702424A (en) 2017-02-24
BR112014029590A2 (pt) 2017-06-27
MX351512B (es) 2017-10-17
MX2014014278A (es) 2015-06-04
ZA201409502B (en) 2017-06-28
AU2012381141A1 (en) 2014-12-18
WO2013180606A1 (en) 2013-12-05
AU2012381141B2 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
MX373851B (es) Métodos de administración de tratamiento con pirfenidona.
BR112014032699A2 (pt) métodos de tratamento de síndrome metabólica pediátrica
TN2014000356A1 (en) Heterocyclyl compounds as mek inhibitors
IN2014DN09434A (es)
PH12015500115B1 (en) Glucagon analogues
PH12014501997A1 (en) Esketamine for the treatment of treatment-refractory or treatment-resistant depression
UA115139C2 (uk) Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
UA113962C2 (xx) Фармацевтична композиція, яка містить апоморфін як активний інгредієнт
MX2019008817A (es) Formulacion de liberacion prolongada para reducir la frecuencia de miccion y metodo de uso de la misma.
MD20140123A2 (ro) Agenţi terapeutici optimizaţi pentru administrare subcutanată
WO2014153385A3 (en) Methods of treating metabolic disorders
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
BR112015001627A2 (pt) composição farmacêutica, respectivos usos e método para diminuir a frequência de micção
MX2014010989A (es) Un metabolito de iloperidona para uso en el tratamiento de trastornos psiquiatricos.
UA111785C2 (uk) Композиція для лікування бородавок та спосіб лікування бородавок
CO6950469A2 (es) Composiciones farmacéuticas microparticuladas conteniendo antiparasitários para terapia subcutánea prolongada, uso de dichas composiciones farmacéuticas para la producción de un medicamento y método de tratamiento de parasitosis
MX2014013083A (es) Composicion farmaceutica inyectable de dexketoprofeno y tramadol.
ES2422563A1 (es) Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma
EA201491769A1 (ru) Фармацевтическая композиция с фиксированной дозой, содержащая мометазон и азеластин
PH12015500178A1 (en) Injectable supersaturated acetaminophen solution for spinal administration
BR112015022000A8 (pt) preparação de combinação farmacêutica, composição farmacêutica e uso da preparação de combinação
PL414785A1 (pl) Kwas 3-dodecylosulfanylomasłowy do zastosowania jako lek, zwłaszcza do zapobiegania rozwojowi insulinooporności oraz kompozycja farmaceutyczna zawierająca kwas 3-dodecylosulfanylomasłowy jako substancję czynną
PL396438A1 (pl) Wykorzystanie melatoniny do wytwarzania leku do nowego zastosowania
WO2014170820A3 (en) A pharmaceutical combination for treating tuberculosis